Back to News
Market Impact: 0.3
Micro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring Tech
Source: benzinga.com
Healthcare & BiotechRegulation & LegislationCompany Fundamentals
Profusa (NASDAQ: PFSA) stock surged Thursday after GMED issued a positive decision certifying the company’s quality-management system to ISO 13485. The certification is a favorable regulatory-quality milestone for the micro-cap healthcare company and may support commercialization and compliance efforts.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.55
Ticker Sentiment
PFSA0.80
More News
- Jensen Huang’s $21 billion net worth in AI rout—Nvidia’s recovery will be ‘capped’ after he admitted affair with alleged Chinese spy
- Nvidia's CEO turmoil gives newly empowered Democrats fresh ammunition in pursuit of oversight
- Paraguay raids ex-president’s home: Why a bank crash brought down Pena
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- Musk says Tesla will refund some Cybertruck deposits, defends decision to end production
- UniCredit CEO Plots Commerzbank Governance Overhaul